FDA Inspection
South Texas Blood & Tissue CenterSouth Texas Blood & Tissue Center – FDA Inspection, Jun 19, 2018
Record Details
This FDA Inspection record concerns South Texas Blood & Tissue Center, with an inspection on June 19, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 233db9fa-1f67-4545-bce9-b361d85018cd
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1057467
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of South Texas Blood & Tissue Center
12| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2025 | Not classified | Dallas District Office | |
| June 9, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 20, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 14, 2020 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 15, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for South Texas Blood & Tissue Center
- FDA Inspection 1279560 - 2025-08-14
- FDA Inspection 1172990 - 2022-06-09
- FDA Inspection 1122018 - 2020-02-20
- FDA Inspection 1117859 - 2020-02-14
- FDA Inspection 1021713 - 2017-06-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.